New Zealand vs Serbia: Number of clinical trials
New Zealand
20 trials
in 2024
Serbia
20 trials
in 2024
New Zealand rank
55th
Serbia rank
55th
Number of clinical trials over time
- New Zealand
- Serbia
How they compare
New Zealand currently reports 20 trials against 20 trials in Serbia, a difference of 0 trials.
The two have swapped places 3 times across 19 shared years of data; in 2006 it was New Zealand ahead.
New Zealand ranks 55th and Serbia ranks 55th of 153 countries.
New Zealand has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | New Zealand | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.75 trials | 2 trials | 4.75 trials | New Zealand |
| 2010s | 15 trials | 8.3 trials | 6.7 trials | New Zealand |
| 2020s | 17 trials | 11.6 trials | 5.4 trials | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of clinical trials, New Zealand or Serbia?
- New Zealand, at 20 trials against 20 trials in Serbia as of 2024.
- What is the difference in number of clinical trials between New Zealand and Serbia?
- 0 trials, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Serbia?
- 19 years are reported by both, from 2006 to 2024.
- How do New Zealand and Serbia rank globally for number of clinical trials?
- New Zealand ranks 55th and Serbia ranks 55th of 153 countries.
- Where does this data come from?
- ClinicalTrials.gov (2025) – with major processing by Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Annual number of completed clinical trials registered in the ClinicalTrials.gov database for each country. Registration in the ClinicalTrials database is mandatory for trials in the United States, but voluntary for other countries.